L3MBTL4 and breast carcinoma: Interestingly, L3MBTL4 is centromeric and in close proximity to the loss of heterozygosity (LOH) region spanning EPB41L3 previously reported in non-small cell lung carcinomas [1], breast carcinomas [3], and meningiomas [31].